touchPODCAST

touchMDT for touchONCOLOGY

 

Beyond tumor control: Long-term management, recurrence and survivorship in TGCT

 

Listen to our expert faculty explore key aspects of longitudinal tenosynovial giant cell tumor (TGCT) care, with a focus on monitoring, long-term outcomes, and optimizing care through coordinated multidisciplinary follow-up.

 

The multidisciplinary team

• Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
• Medical oncologist—Prof. Dr. Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands

 

This touchPODCAST is for HCPs outside of the UK and Ireland only.

 

This activity is funded by an independent medical education grant from Merck KGaA. 

 

This activity is jointly provided by USF Health and touchIME. 

touchIME is an EBAC® accredited provider.

 

For further information visit our website: www.touchoncology.com

touchMDT for touchONCOLOGY

 

Beyond tumor control: Long-term multidisciplinary management of TGCT

 

Listen to our expert faculty explore the long-term multidisciplinary management of tenosynovial giant cell tumor (TGCT), including treatment decision-making, the CSF-1R inhibitor landscape, and regional care differences across the USA, Europe, and China.

 

The multidisciplinary team

• Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
• Medical oncologist—Prof. Dr. Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands
• Orthopedic oncologist—Prof. Xiaohui Niu, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China

 

This touchPODCAST is for HCPs outside of the UK and Ireland only.

 

This activity is funded by an independent medical education grant from Merck KGaA. 

 

This activity is jointly provided by USF Health and touchIME. 

touchIME is an EBAC® accredited provider.

 

For further information visit our website: www.touchoncology.com

touchMDT for touchONCOLOGY

 

Recognizing TGCT earlier: Improving clinical recognition

 

Listen to our expert faculty explore key clinical features and imaging hallmarks of tenosynovial giant cell tumor (TGCT), focusing on clinical red flags, differential diagnoses, and timely referral pathways to specialist sarcoma multidisciplinary teams.

 

The multidisciplinary team

• Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA
• Orthopedic surgeon—Dr. Brian Brigman, Duke Cancer Center, Durham, NC, USA

 

This touchPODCAST is for HCPs outside of the UK and Ireland only.

 

This activity is funded by an independent medical education grant from Merck KGaA. 

 

This activity is jointly provided by USF Health and touchIME. 

touchIME is an EBAC® accredited provider.

 

For further information visit our website: www.touchoncology.com

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen as Dr. Karolinne Rocha shares her insights on the clinical, diagnostic, and patient-specific factors that shape presbyopia-correcting intraocular lens (PCIOL) selection. She also discusses how shared decision-making and counseling can align patient expectations with likely outcomes, including in patients with previous refractive surgery.

The expert:

• Dr. Karolinne Rocha, Medical University of South Carolina, Storm Eye Institute, Charleston, SC, USA

This touchPODCAST is for HCPs outside of the UK.

This educational activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

 

For further information visit our website: 

https://touchophthalmology.org 

touchEXPERT FOCUS for touchONCOLOGY

Dr. Sara Tolaney, a leading breast medical oncologist, shares insights into the distinct toxicity profiles of antibody–drug conjugates (ADCs) approved for metastatic breast cancer (mBC). She explores practical approaches for monitoring, recognizing, and diagnosing ADC-related side effects, and discusses evidence-based strategies for managing treatment-related toxicities. She also provides guidance to support timely intervention to optimize the care of patients with mBC receiving ADCs.

The experts

• Dr. Sara Tolaney, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Gilead Sciences, Inc.

The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com

touchEXPERT FOCUS for touchENDOCRINOLOGY

Listen to a series of interviews with Dr. Sheila Mody who will provide her expert insights into oral and nonoral hormonal contraceptive options, guidance on correct use of transdermal patches and strategies to support shared decision-making in selection of hormonal contraceptives.

The expert:

• Dr. Sheila Mody based in San Diego, CA, USA

This touchPODCAST is for HCPs in the USA only.

This program is supported in part by:

An independent medical educational grant from Mylan Inc., a Viatris Company.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

For further information visit our website: www.touchENDOCRINOLOGY.com

touchEXPERT FOCUS for touchENDOCRINOLOGY and touchHEPATOLOGY

Hear from our expert faculty as they share insights into the pathophysiology, treatment, and multidisciplinary management of glycogen storage disease type Ia (GSDIa). This series of short interviews explores the clinical manifestations of the disorder and highlights how day-to-day standard of care requires a coordinated, multidisciplinary approach. 

The experts:

• Dr. Deeksha Bali, Duke University Medical Center, Durham, NC, USA
• Dr David Rodriguez-Buritica, The University of Texas Health Science Center at Houston (UTHealth Houston), TX, USA
• Dr. Kadakkal Radhakrishnan, Cleveland Clinic, OH, USA

This touchPODCAST is for HCPs in the USA only.

This activity is funded by an independent medical education grant from Ultragenyx Pharmaceutical Inc.

The activity is jointly provided by USF Health and touchIME.

For further information, please visit our websites: www.touchENDOCRINOLOGY.com and www.touchHEPATOLOGY.com

Listen to our expert faculty discuss multidisciplinary care for cardiac amyloidosis, including referral pathways, coordinated treatment decisions and collaboration between specialist centers and local care teams. They also explore monitoring and follow-up for cardiac amyloidosis.

 

The multidisciplinary team:

• Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
• Hematologist – Dr. Yawara Kawano, Kumamoto University Hospital, Kumamoto City, Japan
• Amyloidosis specialist with a renal focus – Dr. Paolo Milani, University of Pavia, Pavia, Italy 
• Amyloidosis MDT nurse/coordinator – Ms. Christine Chiti, Royal Free London NHS Foundation Trust, London, UK

 

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is supported by an independent medical education grant from Alexion Pharma GmbH.

Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.

For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY

Listen to our expert faculty discuss multidisciplinary treatment decisions for amyloid light-chain amyloidosis (AL), including cardiac and renal care, treatment tolerability and frailty. They also explore emerging fibril-directed therapies and their potential role alongside plasma-cell–directed treatment, informed by clinical evidence and local approval.

The multidisciplinary team:

• Hematologist – Dr. Yawara Kawano, Kumamoto University Hospital, Kumamoto City, Japan
• Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
• Amyloidosis specialist with a renal focus – Dr. Paolo Milani, University of Pavia, Pavia, Italy 
• Amyloidosis MDT nurse/coordinator – Ms. Christine Chiti, Royal Free London NHS Foundation Trust, London, UK

 

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is supported by an independent medical education grant from Alexion Pharma GmbH.

Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.

For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY

Listen to our expert faculty explore a shared diagnostic pathway for cardiac amyloidosis, including clinical and imaging red flags, monoclonal-protein testing, and the role of biopsy and amyloid typing. They also explore multidisciplinary collaboration and when to prioritize ruling out amyloid light-chain amyloidosis (AL).

 

The multidisciplinary team:

• Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
• Hematologist – Dr. Yawara Kawano, Kumamoto University Hospital, Kumamoto City, Japan
• Amyloidosis specialist with a renal focus – Dr. Paolo Milani, University of Pavia, Pavia, Italy 

 

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is supported by an independent medical education grant from Alexion Pharma GmbH.

Jointly provided by Partners for Advancing Clinical Education and touchIME.
touchIME is an EBAC® accredited provider.

For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY